Skip to Main Content

A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (MAST)

Principal Investigator

Jaime Merchan

Enrollment Status

Open

Clinical Trial ID

Institutional Protocol # 20220554

Clinical Trial Summary


Phase

Phase I


Funding Agency/Sponsor

Industrial


Disease

Prostate, Bladder, and Kidney Cancers



Contact Information

Phone Number 305-243-2647